$NDRA is currently experiencing significant trading activity, with about 70,000 shares representing a 5% ownership stake valued at approximately $35,000 at the current price. The stock has been identified as a potential bounce play following a 1-for-50 reverse stock split that reduced its outstanding shares to around 1.4 million. However, it has since fallen below $1 and has traded nearly 20 times its outstanding shares in just three days, with a 5-period Relative Strength Index (RSI) at 8.6, indicating high risk. The company recently delayed its earnings conference call, which has raised speculation about potential significant news. Additionally, there are concerns regarding the sustainability of the claimed outstanding shares, as there appears to be a pattern of warrant holders converting and selling their shares. In related news, $ADN.AX has seen a dramatic rise, described as a 47-bagger over 13 months, but has now returned to its original placement price of $0.009 per share following a recent placement. Meanwhile, $ADMA has gained recognition as the top stock on the IBD Top 50 list, noted for strong accumulation volume patterns and added to the PEG watchlist for future consideration.